Maximus, Inc. (NYSE:MMS) Plans $0.30 Quarterly Dividend

Maximus, Inc. (NYSE:MMS - Get Free Report) declared a quarterly dividend on Monday, April 7th, RTT News reports. Shareholders of record on Thursday, May 15th will be given a dividend of 0.30 per share by the health services provider on Saturday, May 31st. This represents a $1.20 annualized dividend and a dividend yield of 1.75%. The ex-dividend date is Thursday, May 15th.

Maximus has raised its dividend by an average of 2.3% per year over the last three years. Maximus has a dividend payout ratio of 18.9% meaning its dividend is sufficiently covered by earnings. Analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 20.8%.

Maximus Stock Performance

Shares of MMS stock traded up $0.94 on Friday, hitting $68.41. The company's stock had a trading volume of 527,898 shares, compared to its average volume of 548,296. Maximus has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a market capitalization of $3.87 billion, a PE ratio of 14.71 and a beta of 0.68. The stock's 50 day moving average is $67.90 and its 200-day moving average is $76.15. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities research analysts expect that Maximus will post 6.15 earnings per share for the current fiscal year.

Remove Ads

Analysts Set New Price Targets

MMS has been the topic of several recent analyst reports. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research note on Thursday, January 2nd.

Insider Activity

In other news, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.